News from
BayBG Venture Capital

Conxai scales agentic AI to automate complex construction workflows with fresh capital from BayBG and Capricorn Partners.

07 April 2026

Conxai has secured €5 million in financing from BayBG Venture Capital, Capricorn Partners and existing investors to further develop its AI platform and expand internationally.

Successful Exit: BayBG Venture Capital Sells Its Stake in Specialty Pharma Company AMW

05 March 2026

BayBG Venture Capital successfully exits AMW, a specialty pharma company for biodegradable drug delivery systems. Ren Life Sciences and Juno Capital Partners become new majority shareholders as AMW enters its next growth phase.

Venture Capital Kickoff 2026 in Munich

11 January 2026

Nearly 200 startups, investors, and ecosystem partners gathered at the Venture Capital Kickoff 2026 in Munich, one of the key networking events for the Bavarian VC community.

BayBG Venture Capital provides growth financing for HealthTech platform AlfaDocs

01 October 2025

We’re proud to continue our partnership with AlfaDocs – the patient-first cloud platform transforming the digitalization of medical and dental practices in Europe.

BayBG announces disposal of investment in IDnow

29 April 2025

Corsair Capital acquired a majority stake and enables digital identity leader IDnow to enter next stage of growth and innovation

Joint Kick-off by BayBG Venture Capital, Cipio Partners, VC Magazin, and WIPIT

11 January 2025

The Munich VC scene came together once again for the traditional Venture Capital Kick-off hosted at BayBG. More than 200 startups, investors, and key players gathered for this collaborative event organized by BayBG, Cipio Partners, VC Magazin, and the law firm WIPIT.